Solventum (MEX:SOLV) Accounts Receivable : MXN21,773 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Solventum Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Solventum's accounts receivables for the quarter that ended in Dec. 2024 was MXN21,773 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Solventum's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 45.91.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Solventum's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was MXN-1,143.11.

Solventum Accounts Receivable Historical Data

The historical data trend for Solventum's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Accounts Receivable Chart

Solventum Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Receivable

24,144.98

22,829.82

22,287.19

21,773.35

Solventum Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Receivable	Get a 7-Day Free Trial						22,287.19	20,247.43	18,833.07	21,757.78	21,773.35

Solventum Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Solventum Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Solventum's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	21773.351	/	43275.577	*	91
=	45.91

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Solventum's accounts receivable are only considered to be worth 75% of book value:

Solventum's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(15892.043	+	0.75 * 21773.351	+	0.5 * 20125.75	-	239798.838
-	0	-	0)	/	172.786
=	-1,143.11

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Solventum Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Solventum's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Solventum Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (MEX:SOLV) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

SOLV:USA KB7:Germany

Address

2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144

Website

https://www.solventum.com/en-us/home

Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.